Sefer Gezer to Treatment Outcome
This is a "connection" page, showing publications Sefer Gezer has written about Treatment Outcome.
Connection Strength
0.033
-
Remicade as TNF suppressor in patients with myelodysplastic syndromes. Leuk Lymphoma. 2004 Oct; 45(10):2099-104.
Score: 0.008
-
Thalidomide produces transfusion independence in long-standing refractory anemias of patients with myelodysplastic syndromes. Blood. 2001 Aug 15; 98(4):958-65.
Score: 0.007
-
High remission rate in acute myeloblastic leukemia with only two days of chemotherapy. Leuk Lymphoma. 2001 Apr; 41(3-4):333-6.
Score: 0.006
-
Poor prognosis acute myelogenous leukemia: 1 - response to treatment with high dose cytarabine/mitoxantrone/ethyol @ (Amifostine). Leuk Res. 2000 Aug; 24(8):671-80.
Score: 0.006
-
Patients with myelodysplastic syndromes benefit from palliative therapy with amifostine, pentoxifylline, and ciprofloxacin with or without dexamethasone. Blood. 2000 Mar 01; 95(5):1580-7.
Score: 0.006